Clinical Trial Update: Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated a reduced-intensity regimen as conditioning before donor bone marrow transplant in patients with myelodysplastic syndromes, with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndromes

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED | Results posted: 2015-01-19